US Stock MarketDetailed Quotes

BEAM Beam Therapeutics

Watchlist
  • 27.200
  • +1.360+5.26%
Close Nov 27 16:00 ET
  • 27.200
  • 0.0000.00%
Post 16:34 ET
2.25BMarket Cap-17215P/E (TTM)

Beam Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Assets
Current assets
Cash, cash equivalents and short term investments
-8.83%925.76M
-6.04%1.01B
3.31%1.09B
10.36%1.19B
10.36%1.19B
-7.23%1.02B
-7.98%1.07B
-13.34%1.06B
11.65%1.08B
11.65%1.08B
-Cash and cash equivalents
36.18%230.2M
29.80%292.76M
15.24%287.85M
87.27%435.9M
87.27%435.9M
8.01%169.05M
-15.09%225.54M
-15.85%249.77M
-58.43%232.77M
-58.43%232.77M
-Short-term investments
-17.82%695.55M
-15.58%715.4M
-0.37%806.71M
-10.81%753.98M
-10.81%753.98M
-9.77%846.41M
-5.89%847.47M
-12.54%809.7M
108.40%845.37M
108.40%845.37M
Other current assets
-17.88%19.78M
-2.36%21.28M
15.26%27.16M
43.39%21.17M
43.39%21.17M
--24.08M
--21.79M
--23.56M
100.57%14.76M
100.57%14.76M
Total current assets
-9.04%945.53M
-5.97%1.03B
3.57%1.12B
10.81%1.21B
10.81%1.21B
-6.26%1.04B
-7.21%1.09B
-12.62%1.08B
-14.15%1.09B
-14.15%1.09B
Non current assets
Net PPE
-8.95%218.21M
-7.40%224.35M
-3.38%229.95M
1.57%237.81M
1.57%237.81M
5.71%239.66M
8.39%242.28M
19.09%237.98M
25.22%234.13M
25.22%234.13M
-Gross PPE
0.14%284.87M
1.29%285.54M
4.68%285.56M
8.96%287.99M
8.96%287.99M
12.47%284.48M
14.47%281.91M
24.47%272.8M
30.16%264.3M
30.16%264.3M
-Accumulated depreciation
-48.74%-66.66M
-54.39%-61.19M
-59.73%-55.61M
-66.33%-50.18M
-66.33%-50.18M
-70.90%-44.82M
-74.20%-39.63M
-80.08%-34.82M
-87.61%-30.17M
-87.61%-30.17M
Other non current assets
-32.70%7.63M
-55.50%7.48M
-28.21%8.14M
-26.01%10.87M
-26.01%10.87M
-22.51%11.33M
12.26%16.8M
-19.50%11.34M
1.49%14.69M
1.49%14.69M
Total non current assets
-10.02%225.83M
-10.52%231.83M
-4.51%238.09M
-0.06%248.67M
-0.06%248.67M
4.00%250.99M
8.64%259.08M
16.55%249.32M
23.52%248.82M
23.52%248.82M
Total assets
-9.23%1.17B
-6.84%1.26B
2.06%1.36B
8.79%1.46B
8.79%1.46B
-4.42%1.29B
-4.55%1.35B
-8.33%1.33B
-9.00%1.34B
-9.00%1.34B
Liabilities
Current liabilities
Payables
19.99%3.81M
-35.68%4.43M
-80.16%2.79M
-82.09%1.62M
-82.09%1.62M
-54.77%3.18M
-2.95%6.89M
124.43%14.06M
20.81%9.03M
20.81%9.03M
-accounts payable
19.99%3.81M
-35.68%4.43M
-80.16%2.79M
-82.09%1.62M
-82.09%1.62M
-54.77%3.18M
-2.95%6.89M
124.43%14.06M
20.81%9.03M
20.81%9.03M
Current accrued expenses
52.58%35.48M
69.23%33.96M
158.00%54.51M
233.19%61.73M
233.19%61.73M
72.16%23.25M
10.03%20.07M
-53.58%21.13M
-62.22%18.53M
-62.22%18.53M
Current debt and capital lease obligation
8.24%12.94M
10.00%12.64M
9.18%12.18M
23.10%12.78M
23.10%12.78M
21.66%11.95M
20.82%11.49M
19.21%11.16M
37.67%10.38M
37.67%10.38M
-Current capital lease obligation
8.24%12.94M
10.00%12.64M
9.18%12.18M
23.10%12.78M
23.10%12.78M
21.66%11.95M
20.82%11.49M
19.21%11.16M
37.67%10.38M
37.67%10.38M
Current deferred liabilities
-41.80%89.33M
-38.96%84.93M
-49.48%72.11M
-49.47%68.71M
-49.47%68.71M
-4.01%153.48M
-0.39%139.13M
24.07%142.74M
57.61%135.97M
57.61%135.97M
Other current liabilities
-25.65%10.98M
44.05%31.74M
61.56%40.75M
27.47%38.96M
27.47%38.96M
-59.67%14.76M
-23.54%22.03M
-29.64%25.22M
-40.60%30.56M
-40.60%30.56M
Current liabilities
-24.56%166.24M
-15.37%177.33M
-14.87%187.22M
-8.06%205.57M
-8.06%205.57M
-7.74%220.37M
-1.29%209.54M
0.52%219.93M
4.76%223.6M
4.76%223.6M
Non current liabilities
Long term debt and capital lease obligation
-7.16%149.13M
-6.87%152.6M
-5.66%155.94M
-5.17%159.91M
-5.17%159.91M
-2.69%160.64M
-0.08%163.85M
21.51%165.3M
25.08%168.63M
25.08%168.63M
-Long term capital lease obligation
-7.16%149.13M
-6.87%152.6M
-5.66%155.94M
-5.17%159.91M
-5.17%159.91M
-2.69%160.64M
-0.08%163.85M
21.51%165.3M
25.08%168.63M
25.08%168.63M
Non current deferred liabilities
-53.62%57.82M
-51.67%75.49M
-42.01%99.57M
-45.65%109.89M
-45.65%109.89M
-37.14%124.65M
-25.20%156.2M
-23.72%171.71M
-22.92%202.18M
-22.92%202.18M
Derivative product liabilities
--5.28M
----
----
----
----
----
----
----
----
----
Other non current liabilities
-73.31%1.59M
-86.12%1.76M
-74.31%3.58M
-78.17%3.02M
-78.17%3.02M
-82.30%5.94M
-61.80%12.66M
-68.67%13.92M
-62.76%13.84M
-62.76%13.84M
Total non current liabilities
-26.58%213.81M
-30.92%229.84M
-26.17%259.09M
-29.07%272.82M
-29.07%272.82M
-26.63%291.23M
-18.04%332.71M
-13.47%350.92M
-11.43%384.65M
-11.43%384.65M
Total liabilities
-25.71%380.05M
-24.91%407.17M
-21.82%446.31M
-21.35%478.39M
-21.35%478.39M
-19.53%511.59M
-12.29%542.24M
-8.57%570.85M
-6.09%608.24M
-6.09%608.24M
Shareholders'equity
Share capital
4.03%826K
5.64%824K
10.62%823K
14.61%816K
14.61%816K
12.62%794K
10.95%780K
6.59%744K
4.09%712K
4.09%712K
-common stock
4.03%826K
5.64%824K
10.62%823K
14.61%816K
14.61%816K
12.62%794K
10.95%780K
6.59%744K
4.09%712K
4.09%712K
-Preferred stock
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Retained earnings
-10.77%-1.48B
-11.56%-1.38B
-11.68%-1.29B
-12.53%-1.19B
-12.53%-1.19B
-30.78%-1.33B
-35.97%-1.24B
-37.77%-1.15B
-37.63%-1.06B
-37.63%-1.06B
Paid-in capital
7.20%2.27B
9.00%2.23B
14.97%2.2B
21.05%2.17B
21.05%2.17B
21.61%2.11B
19.64%2.05B
14.79%1.92B
12.43%1.79B
12.43%1.79B
Gains losses not affecting retained earnings
186.91%1.76M
44.91%-1.11M
-20.39%-921K
124.86%604K
124.86%604K
56.70%-2.02M
51.91%-2.02M
71.76%-765K
-4,760.00%-2.43M
-4,760.00%-2.43M
Total stockholders'equity
1.59%791.32M
5.23%854.09M
19.96%913.49M
33.79%981.33M
33.79%981.33M
9.02%778.94M
1.43%811.64M
-8.15%761.51M
-11.28%733.47M
-11.28%733.47M
Total equity
1.59%791.32M
5.23%854.09M
19.96%913.49M
33.79%981.33M
33.79%981.33M
9.02%778.94M
1.43%811.64M
-8.15%761.51M
-11.28%733.47M
-11.28%733.47M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
--
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Assets
Current assets
Cash, cash equivalents and short term investments -8.83%925.76M-6.04%1.01B3.31%1.09B10.36%1.19B10.36%1.19B-7.23%1.02B-7.98%1.07B-13.34%1.06B11.65%1.08B11.65%1.08B
-Cash and cash equivalents 36.18%230.2M29.80%292.76M15.24%287.85M87.27%435.9M87.27%435.9M8.01%169.05M-15.09%225.54M-15.85%249.77M-58.43%232.77M-58.43%232.77M
-Short-term investments -17.82%695.55M-15.58%715.4M-0.37%806.71M-10.81%753.98M-10.81%753.98M-9.77%846.41M-5.89%847.47M-12.54%809.7M108.40%845.37M108.40%845.37M
Other current assets -17.88%19.78M-2.36%21.28M15.26%27.16M43.39%21.17M43.39%21.17M--24.08M--21.79M--23.56M100.57%14.76M100.57%14.76M
Total current assets -9.04%945.53M-5.97%1.03B3.57%1.12B10.81%1.21B10.81%1.21B-6.26%1.04B-7.21%1.09B-12.62%1.08B-14.15%1.09B-14.15%1.09B
Non current assets
Net PPE -8.95%218.21M-7.40%224.35M-3.38%229.95M1.57%237.81M1.57%237.81M5.71%239.66M8.39%242.28M19.09%237.98M25.22%234.13M25.22%234.13M
-Gross PPE 0.14%284.87M1.29%285.54M4.68%285.56M8.96%287.99M8.96%287.99M12.47%284.48M14.47%281.91M24.47%272.8M30.16%264.3M30.16%264.3M
-Accumulated depreciation -48.74%-66.66M-54.39%-61.19M-59.73%-55.61M-66.33%-50.18M-66.33%-50.18M-70.90%-44.82M-74.20%-39.63M-80.08%-34.82M-87.61%-30.17M-87.61%-30.17M
Other non current assets -32.70%7.63M-55.50%7.48M-28.21%8.14M-26.01%10.87M-26.01%10.87M-22.51%11.33M12.26%16.8M-19.50%11.34M1.49%14.69M1.49%14.69M
Total non current assets -10.02%225.83M-10.52%231.83M-4.51%238.09M-0.06%248.67M-0.06%248.67M4.00%250.99M8.64%259.08M16.55%249.32M23.52%248.82M23.52%248.82M
Total assets -9.23%1.17B-6.84%1.26B2.06%1.36B8.79%1.46B8.79%1.46B-4.42%1.29B-4.55%1.35B-8.33%1.33B-9.00%1.34B-9.00%1.34B
Liabilities
Current liabilities
Payables 19.99%3.81M-35.68%4.43M-80.16%2.79M-82.09%1.62M-82.09%1.62M-54.77%3.18M-2.95%6.89M124.43%14.06M20.81%9.03M20.81%9.03M
-accounts payable 19.99%3.81M-35.68%4.43M-80.16%2.79M-82.09%1.62M-82.09%1.62M-54.77%3.18M-2.95%6.89M124.43%14.06M20.81%9.03M20.81%9.03M
Current accrued expenses 52.58%35.48M69.23%33.96M158.00%54.51M233.19%61.73M233.19%61.73M72.16%23.25M10.03%20.07M-53.58%21.13M-62.22%18.53M-62.22%18.53M
Current debt and capital lease obligation 8.24%12.94M10.00%12.64M9.18%12.18M23.10%12.78M23.10%12.78M21.66%11.95M20.82%11.49M19.21%11.16M37.67%10.38M37.67%10.38M
-Current capital lease obligation 8.24%12.94M10.00%12.64M9.18%12.18M23.10%12.78M23.10%12.78M21.66%11.95M20.82%11.49M19.21%11.16M37.67%10.38M37.67%10.38M
Current deferred liabilities -41.80%89.33M-38.96%84.93M-49.48%72.11M-49.47%68.71M-49.47%68.71M-4.01%153.48M-0.39%139.13M24.07%142.74M57.61%135.97M57.61%135.97M
Other current liabilities -25.65%10.98M44.05%31.74M61.56%40.75M27.47%38.96M27.47%38.96M-59.67%14.76M-23.54%22.03M-29.64%25.22M-40.60%30.56M-40.60%30.56M
Current liabilities -24.56%166.24M-15.37%177.33M-14.87%187.22M-8.06%205.57M-8.06%205.57M-7.74%220.37M-1.29%209.54M0.52%219.93M4.76%223.6M4.76%223.6M
Non current liabilities
Long term debt and capital lease obligation -7.16%149.13M-6.87%152.6M-5.66%155.94M-5.17%159.91M-5.17%159.91M-2.69%160.64M-0.08%163.85M21.51%165.3M25.08%168.63M25.08%168.63M
-Long term capital lease obligation -7.16%149.13M-6.87%152.6M-5.66%155.94M-5.17%159.91M-5.17%159.91M-2.69%160.64M-0.08%163.85M21.51%165.3M25.08%168.63M25.08%168.63M
Non current deferred liabilities -53.62%57.82M-51.67%75.49M-42.01%99.57M-45.65%109.89M-45.65%109.89M-37.14%124.65M-25.20%156.2M-23.72%171.71M-22.92%202.18M-22.92%202.18M
Derivative product liabilities --5.28M------------------------------------
Other non current liabilities -73.31%1.59M-86.12%1.76M-74.31%3.58M-78.17%3.02M-78.17%3.02M-82.30%5.94M-61.80%12.66M-68.67%13.92M-62.76%13.84M-62.76%13.84M
Total non current liabilities -26.58%213.81M-30.92%229.84M-26.17%259.09M-29.07%272.82M-29.07%272.82M-26.63%291.23M-18.04%332.71M-13.47%350.92M-11.43%384.65M-11.43%384.65M
Total liabilities -25.71%380.05M-24.91%407.17M-21.82%446.31M-21.35%478.39M-21.35%478.39M-19.53%511.59M-12.29%542.24M-8.57%570.85M-6.09%608.24M-6.09%608.24M
Shareholders'equity
Share capital 4.03%826K5.64%824K10.62%823K14.61%816K14.61%816K12.62%794K10.95%780K6.59%744K4.09%712K4.09%712K
-common stock 4.03%826K5.64%824K10.62%823K14.61%816K14.61%816K12.62%794K10.95%780K6.59%744K4.09%712K4.09%712K
-Preferred stock --0--0--0--0--0--0--0--0--0--0
Retained earnings -10.77%-1.48B-11.56%-1.38B-11.68%-1.29B-12.53%-1.19B-12.53%-1.19B-30.78%-1.33B-35.97%-1.24B-37.77%-1.15B-37.63%-1.06B-37.63%-1.06B
Paid-in capital 7.20%2.27B9.00%2.23B14.97%2.2B21.05%2.17B21.05%2.17B21.61%2.11B19.64%2.05B14.79%1.92B12.43%1.79B12.43%1.79B
Gains losses not affecting retained earnings 186.91%1.76M44.91%-1.11M-20.39%-921K124.86%604K124.86%604K56.70%-2.02M51.91%-2.02M71.76%-765K-4,760.00%-2.43M-4,760.00%-2.43M
Total stockholders'equity 1.59%791.32M5.23%854.09M19.96%913.49M33.79%981.33M33.79%981.33M9.02%778.94M1.43%811.64M-8.15%761.51M-11.28%733.47M-11.28%733.47M
Total equity 1.59%791.32M5.23%854.09M19.96%913.49M33.79%981.33M33.79%981.33M9.02%778.94M1.43%811.64M-8.15%761.51M-11.28%733.47M-11.28%733.47M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----------------Unqualified Opinion--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data

Investment Theme Gene Editing
Gene Editing
Intraday+0.56%
ARK Portfolio
ARK Portfolio
Intraday-0.56%